UCB - Current Assets

Stock Price
262.10
Daily Change
1.50 0.58%
Monthly
11.58%
Yearly
42.06%
Q1 Forecast
249.19

UCB reported EUR4.79B in Current Assets for its fiscal semester ending in December of 2024.





Current Assets Change Date
Alcon AG USD 6.33B 27M Sep/2025
Almirall EUR 714.05M 27.09M Jun/2025
Amarin USD 628.33M 21.52M Sep/2025
argenx SE USD 5.83B 946.64M Jun/2025
AstraZeneca USD 29.94B 1B Sep/2025
Bayer EUR 32.88B 873M Sep/2025
Galapagos EUR 3.16B 93.29M Sep/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.84B 169M Sep/2025
GRIFOLS EUR 5.35B 102.57M Sep/2025
Hikma Pharmaceutical USD 2.56B 294M Jun/2025
Lonza CHF 5.44B 113M Dec/2024
Merck EUR 12.88B 680M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Orion EUR 1.1B 89.6M Sep/2025
Recordati EUR 1.71B 144.32M Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
UCB EUR 4.79B 1.47B Dec/2024
Unibail Rodamco EUR 7.12B 550.2M Dec/2024